Free Trial

Xometry (NASDAQ:XMTR) Posts Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Xometry logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Xometry exceeded quarterly expectations, reporting EPS of $0.28 versus the $0.19 consensus estimate and revenue of $252.44 million versus $235.54 million expected. Revenue increased 39.5% year over year.
  • The stock opened at $95.49, with a market capitalization of approximately $4.95 billion; despite strong growth, the company remained unprofitable, posting a negative 3.82% net margin.
  • Analyst sentiment is generally positive, with a consensus “Moderate Buy” rating and a $113.18 price target, while insiders sold 64,699 shares worth about $6.17 million over the past 90 days.
  • MarketBeat previews the top five stocks to own by December 1st.

Xometry (NASDAQ:XMTR - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.19 by $0.09, FiscalAI reports. Xometry had a negative return on equity of 2.88% and a negative net margin of 3.82%. The firm had revenue of $252.44 million during the quarter, compared to analysts' expectations of $235.54 million. During the same period in the previous year, the business earned $0.11 earnings per share. The firm's revenue for the quarter was up 39.5% on a year-over-year basis.

Xometry Price Performance

Xometry stock opened at $95.49 on Tuesday. The company has a current ratio of 3.21, a quick ratio of 3.20 and a debt-to-equity ratio of 0.41. The company has a 50-day moving average price of $96.37 and a 200 day moving average price of $76.22. Xometry has a 12-month low of $35.86 and a 12-month high of $112.94. The stock has a market cap of $4.95 billion, a P/E ratio of -159.15 and a beta of 1.23.

Insider Buying and Selling

In other news, Director Fabio Rosati sold 8,100 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $91.45, for a total value of $740,745.00. Following the completion of the sale, the director owned 93,567 shares of the company's stock, valued at $8,556,702.15. This represents a 7.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Emily Rollins sold 5,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $84.31, for a total transaction of $421,550.00. Following the sale, the director owned 15,136 shares of the company's stock, valued at $1,276,116.16. This represents a 24.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 64,699 shares of company stock worth $6,169,735 over the last ninety days. 9.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of brokerages have recently commented on XMTR. Citizens Jmp reiterated a "market outperform" rating and issued a $120.00 target price on shares of Xometry in a research report on Monday, September 21st. The Goldman Sachs Group boosted their price target on shares of Xometry from $78.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, August 5th. UBS Group upped their price objective on shares of Xometry from $88.00 to $95.00 and gave the company a "neutral" rating in a research note on Wednesday, August 5th. Citigroup reiterated a "market outperform" rating on shares of Xometry in a report on Monday, September 21st. Finally, Rosenblatt Securities raised their target price on shares of Xometry from $110.00 to $120.00 and gave the stock a "buy" rating in a research note on Tuesday, September 22nd. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $113.18.

View Our Latest Research Report on Xometry

About Xometry

(Get Free Report)

Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.

See Also

Earnings History for Xometry (NASDAQ:XMTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines